Rare juvenile dinosaur 'Ceratosaurus' fossil sells for $30.5 million at Sotheby's auction
A rare juvenile Ceratosaurus fossil believed to be the only one of its kind sold for a jaw-dropping $30.5 million at Sotheby's on Wednesday(July 16).The fossil, uncovered in 1996 at Bone Cabin Quarry in Wyoming, is one of only four known Ceratosaurus skeletons ever discovered and the only juvenile among them. Measuring over six feet tall and nearly 11 feet long, the 150-million-year-old relic includes 139 fossilized bone elements, 57 of which form what Sotheby's calls a 'superb, virtually complete skull.'Described by the auction house as 'one of the finest and most complete examples of its kind ever found,' the dinosaur far surpassed its $4 million to $6 million pre-sale estimate during a dramatic six-minute bidding war between six participants. It previously spent over two decades on display at the Museum of Ancient Life in Utah but has never been formally studied in scientific literature.Ceratosaurus nasicornis was a carnivorous dinosaur known for its distinctive nasal horn, long teeth, and bony armor along its spine and tail. The species roamed North America during the late Jurassic period.While Sotheby's says the unnamed buyer intends to loan the fossil to an institution, paleontologists remain cautious.
'Who has that kind of money to spend on a dinosaur? Certainly not any museums or educational institutions,' said Steve Brusatte, a paleontology professor at the University of Edinburgh. 'My fear is that this skeleton will disappear into the ether into a mansion or a bank vault.'Still, auction officials argue the private market can play a vital role in preserving and promoting scientific specimens.'These stellar results underscore a deep and enduring fascination with the natural world,' said Cassandra Hatton, Sotheby's global head of science and natural history. 'What draws collectors is more than a passion for science; it's curiosity about the forces that shaped our planet.'
The sale follows a trend of surging fossil prices, including last year's record-breaking $44.6 million sale of 'Apex,' a Stegosaurus skeleton that now resides at the American Museum of Natural History.
'Bottom line,' said Brusatte, 'a world where dinosaur skeletons can fetch tens of millions of dollars is not a world where dinosaurs will long be accessible to educate and inspire everyone.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
a day ago
- Time of India
Ozempic and Wegovy may cut dementia risk by 45% and manage diabetes, study finds
Source: Reuters A groundbreaking study has revealed that GLP-1 receptor agonists—including popular weight-loss and diabetes drugs like Ozempic, Wegovy, and Mounjaro- may significantly reduce the risk of developing dementia. The analysis, conducted by Irish researchers and published in JAMA Neurology , involved data from over 164,000 participants and found that these medications reduced the risk of memory-robbing disorders by up to 45 per cent. These findings not only open new avenues for neurological protection but also position GLP-1 drugs as powerful tools in both metabolic and cognitive health management. Study links GLP-1 drugs like Ozempic and Mounjaro to lower dementia risk Researchers from the University of Galway reviewed 26 clinical trials involving 164,531 individuals—65% of whom were men, with an average age of 64. The participants were followed for an average of 31 months. The key discovery: patients taking GLP-1 agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) were 45% less likely to develop dementia compared to those on other glucose-lowering medications. Dr. Catriona Reddin, senior study author, said, 'Our findings suggest that GLP-1 receptor agonists, in particular, may have a protective effect on brain health.' by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo How GLP-1 agonists may protect against dementia Although the exact mechanism remains under investigation, researchers propose several pathways through which GLP-1 medications could shield the brain: Reduced neuroinflammation: These drugs may lower inflammation in the brain, which is known to damage neurons and trigger dementia symptoms. Decrease in amyloid and tau proteins: GLP-1 agonists could suppress the accumulation of toxic proteins linked to Alzheimer's disease. Improved blood vessel health: They may reduce blood pressure and enhance blood flow, preventing vascular dementia. Neurogenesis stimulation: Early research suggests these drugs may promote neural growth in the hippocampus, the brain region essential for memory. GLP-1 drugs may help prevent both diabetes and dementia The new study aligns with earlier research from the University of Florida, which followed 400,000 Americans and reported a 33% lower risk of dementia among GLP-1 users compared to other treatments. This growing body of evidence supports the role of semaglutide and tirzepatide not only in treating type 2 diabetes and obesity but potentially in preventing cognitive decline. Professor Martin O'Donnell, Dean at the University of Galway, emphasised, 'With both diabetes and dementia rising, these findings have major public health implications.' Dementia and diabetes: Twin epidemics in the US The study arrives amid alarming trends: Over 8 million Americans currently live with dementia, with 500,000 new cases diagnosed each year. Diabetes now affects 38 million people in the US; around 12% of the population. According to the Alzheimer's Association, Alzheimer's rates have climbed 25 consecutive years. The intersection of these two epidemics highlights the urgency of therapies that can address both conditions simultaneously. Study highlights need for more GLP-1 brain health data While the findings are promising, researchers caution that more work is needed to confirm the results. Notable limitations include: Lack of data on dementia subtypes like Lewy body and vascular dementia Differences in study design and follow-up durations Unclear long-term cognitive outcomes for different age groups and genders Still, this analysis lays essential groundwork for future research into neurometabolic protection via GLP-1 therapies. Originally celebrated as breakthrough treatments for obesity and diabetes, these medications may now be poised to take on an even broader role in preventing neurodegenerative diseases. As Dr. Reddin concluded, 'This research marks a significant advancement in how we understand the brain benefits of diabetes medications.' This article is based on findings from a study published in JAMA Neurology (July 2024). While the research links GLP-1 drugs like Ozempic and Mounjaro to reduce dementia risk, it is observational and does not prove direct causation. Further studies are needed. Always consult a healthcare provider before making medication decisions. Also Read | 5 coffee routine habits that could be doing more harm than good, say experts
Mint
2 days ago
- Mint
Largest piece of Mars fetches $5.3 million at auction, young dinosaur skeleton steals the show
New York City recently hosted an auction of rare geological and archaeological objects, featuring the largest piece of Mars ever found which was sold for over $5 million. However, it was a rare young dinosaur skeleton which actually stole the show when it fetched more than $30 million in a bidding frenzy. The 54-pound (25-kilogram) rock, officially named NWA 16788 was sold for approximately $5.3 million, including fees and costs, making it the most valuable meteorite ever auctioned. The rock was discovered in the Sahara Desert, Niger by a meteorite hunter in November 2023, after it was blown off the surface of Mars by a massive asteroid strike, according to Sotheby's report, cited by AP. The red, brown and gray meteorite is about 70% larger than the next largest piece of Mars found on Earth and represents nearly 7% of all the Martian pieces currently on this planet, AP reported. Cassandra Hatton, vice chairman for science and natural history at Sotheby's highlighted the rarity of the find, noting that only 400 Martian meteorites out of the more than 77,000 officially recognized meteorites found on Earth are Martian. 'This Martian meteorite is the largest piece of Mars we have ever found by a long shot,' Hatton said. 'So it's more than double the size of what we previously thought was the largest piece of Mars.' Stealing the show was a rare young dinosaur skeleton that fetched an astounding $30.5 million, including fees and costs after a six minutes bidding war among six interested participants. The skeleton is identified as a Ceratosaurus nasicornis, which is one of only four known skeletons of its species and the only juvenile one. The species resemblesthe Tyrannosaurus rex but is smaller. The bidding began with a high advance offer of $6 million, quickly escalating during the live round with bids $500,000 higher than the last and later $1 million higher than the last before ending at $26 million. The winner plans to loan dinosaur skeleton to an institution, Sotheby's told AP. This sale marks the third-highest amount paid for a dinosaur at an auction. A Stegosaurus skeleton called 'Apex' holds the record after it was sold for $44.6 million last year at Sotheby's. Parts of the juvenile dinosaur were found in 1996 near Laramie, Wyoming, at Bone Cabin Quarry, which is considered a gold mine for dinosaur bones. It was acquired last year by Fossilogic, a Utah-based fossil preparation and mounting company. The skeleton is more than 6 feet (2 meters) tall and nearly 11 feet (3 meters) long, and is believed to belong to the lateJurassic period, about 150 million years ago. Ceratosaurus dinosaurs could grow up to 25 feet (7.6 meters) long, while the T. rex could be 40 feet (12 meters) long, the news agency reported.
Mint
2 days ago
- Mint
Anonymous buyer spends ₹263 crore to own 150-million-year-old dinosaur fossil; ‘Bezos or Musk?' wonders social media
A very rare dinosaur fossil has been sold for $30.5 million ( ₹ 263 crore) at an auction in New York. It was a Ceratosaurus, a meat-eating dinosaur with a horn on its nose, sharp teeth and bony armour on its back and tail. The buyer wants to loan it to an institution, which is suitable for a specimen of this 'rarity and importance', Sotheby's auction house said. Professor Steve Brusatte has called such high prices shocking. The dinosaur expert from the University of Edinburgh feels museums cannot afford them. 'While I'm pleased that the buyer might loan the skeleton to a museum to be put on display, at this point, it is just a vague suggestion. The buyer is still anonymous,' Brusatte told CNN. He fears the fossil may end up hidden in a rich person's home and never be seen by the public again. 'My fear is that this skeleton will disappear into the ether, into the mansion of an oligarch or a bank vault to accumulate value as just another investment in the portfolio of a hedge fund, and not see the light of day until it's auctioned again, or maybe never at all,' he added. A Mars meteorite, the biggest found on Earth, was sold for $5.3 million in the same auction. In July 2024, a Stegosaurus fossil named Apex was sold by Sotheby's for $44.6 million ( ₹ 380 crore). Social media wondered who the buyer was. 'Bezos or Musk?' asked one YouTube user. Another called it 'bare bones capitalism'. 'Are you telling me Sotheby's got 4 million in fees?' asked one user as the official price differed from what was seen in the auction video. This fossil is special because it's the only young Ceratosaurus among the four known in the world. It is over 150 million years old. It belongs to Late Jurassic, Kimmeridgian Stage, estimated to have existed 154-149 million years ago. The fossil is 6 feet tall and over 10 feet long, with 139 bones. Its skull is almost complete with 57 bones. It is an 'exceptional, exhibition-ready mounted skeleton', according to Sotheby's. The skull has 43 teeth, along with 5 extra loose teeth. Its sharp teeth and horned nose are clearly visible. The bones are well-preserved, dark in colour and show fine details. Sotheby's says it is one of the best and most complete fossils of its kind. It was expected to sell for $4 to $6 million. However, it got much more after six bidders competed, CNN reported. It was shown at a museum in Utah from 2000 to 2024. Surprisingly, scientists have never formally studied this fossil in a research paper. Experts believe the fossil belonged to a young dinosaur due to the delicate bone structure. The skeleton has been carefully mounted in a dramatic pose with jaws open. It includes ownership documents, x-rays, 3D scans and legal certification. According to Sotheby's, the dinosaur skeleton is offered with full ownership rights.
